JPMorgan Chase & Co. Raises UnitedHealth Group (NYSE:UNH) Price Target to $425.00

Key Points

• JPMorgan Chase & Co. has increased its price target for UnitedHealth Group from $310.00 to $425.00, indicating a potential upside of 13.34% from the current stock price.
• Other analysts have varying ratings and price targets for UnitedHealth, with some setting targets as high as $433.00 and others as low as $198.00.
• UnitedHealth Group reported a quarterly earnings miss with an EPS of $4.08, below the consensus estimate of $4.45, while the company's revenue saw a year-over-year increase of 12.9%.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price target hoisted by research analysts at JPMorgan Chase & Co. from $310.00 to $425.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an "overweight" rating on the healthcare conglomerate's stock. JPMorgan Chase & Co.'s price target would suggest a potential upside of 13.34% from the company's current price.

Other research analysts also recently issued reports about the stock. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an "outperform" rating in a report on Wednesday. Barclays upped their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an "overweight" rating in a report on Thursday. Morgan Stanley upped their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a report on Friday, September 12th. Finally, UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of "Hold" and a consensus price target of $383.09.

UnitedHealth Group Price Performance

UNH traded up $5.05 during trading on Thursday, hitting $374.97. 1,134,528 shares of the stock traded hands, compared to its average volume of 12,682,750. UnitedHealth Group has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a market cap of $339.60 billion, a price-to-earnings ratio of 16.25, a PEG ratio of 2.35 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50 day moving average price of $313.51 and a 200 day moving average price of $352.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts forecast that UnitedHealth Group will post 29.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter worth about $42,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $25,000. Finally, O Brien Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.